Visceral fat cushions or surrounds several internal organs, including your #Heart
#Intestines #Kidneys
#Liver and #gallbladder
#Mesentery #Pancreas
#Stomach Belly #fat includes both #visceral and #subcutaneous fat. #ClevelandClinic

Parenteral Drug Administration: Routes, Angles & Needle Sizes
#ParenteralAdministration #VikaasShandily #NursingSkills #MedicationAdministration #InjectionTechniques #Intradermal #Subcutaneous #Intramuscular #Intravenous #MedicalEducation #NursingEducation

Setback for MSD as German court blocks Keytruda SC launch A court in Germany has granted an injunction that will prevent MSD from distributing the new, subcutaneous version of its cancer drug Keytruda.

A #court in Munich has granted a preliminary #injunction that will prevent #MSD from distributing the #subcutaneous version of its #cancerimmunotherapy Keytruda in the #Germanmarket.

pharmaphorum.com/news/setback...

Healthy BMI, Hidden Heart Attack Risk In today's episode we're unpacking why many healthy-looking individuals - those with a seemingly normal Body Mass Index (BMI) - are unknowingly at a heightened risk for heart attacks and strokes. We discuss the crucial distinction between subcutaneous fat and dangerous visceral fat, often called "belly fat," which is stored around vital organs and drives chronic inflammation. Relying on BMI alone doesn't provide the whole picture. Drawing on a comprehensive new study involving 470,000 participants, we reveal that people with a normal BMI but high waist circumference have significantly elevated chances of high blood pressure, type 2 diabetes, and high triglycerides. Dr. Stanfield explains why this vital metric is often forgotten in clinical practice and provides simple instructions on how you can easily measure your own risk at home. Podcast Resources/References: 1. https://drstanfield.com/en-eu/blogs/articles/why-healthy-people-still-have-heart-attacks

📣 New Podcast! "Healthy BMI, Hidden Heart Attack Risk" on @Spreaker #attack #bloodpressure #bmi #cardiology #cholesterol #circumference #diabetes #fat #health #heart #inflammation #longevity #measurement #metrics #obesity #prevention #risk #subcutaneous #visceral #weight

RocheのLunsumio皮下注製剤、再発・難治性濾胞性リンパ腫に対しEUで条件付き承認 外来投与が約1分に短縮 | STELLANEWS.LIFE Rocheは、再発または難治性濾胞性リンパ腫に対するLunsumio（mosunetuzumab）皮下注製剤が欧州委員会より条件付き販売承認を取得したと発表。投与時間の短縮や有効性、安全性が第1／2相試験で確認され、外来投与の利便性向上に寄与。

Roche’s Lunsumio SC Granted Conditional EU Approval for Relapsed/Refractory Follicular Lymphoma

🔗 Full article: stellanews.life/technology_c...

#Roche #Lunsumio #Mosunetuzumab #FollicularLymphoma #Hematology #CancerTherapy #Subcutaneous #OncologyNews #Biopharma

KEYTRUDA皮下投与型がEUで承認、がん治療で初の1分投与可能な免疫チェックポイント阻害薬 | STELLANEWS.LIFE メルクのKEYTRUDA（ペムブロリズマブ）皮下投与型が欧州委員会により承認。従来の点滴型に比べ、最短1分での投与が可能となり、がん患者の治療選択肢が拡大。

Keytruda SC approved in the EU — the first checkpoint inhibitor enabling 1-minute subcutaneous dosing.

🔗 Full article: stellanews.life/technology_c...

#Keytruda #MSD #Merck #Pembrolizumab #ImmunoOncology #CheckpointInhibitor #Subcutaneous #CancerTreatment #Oncology #Innovation

#Eisai and #Biogen have won FDA approval for a #subcutaneous injection version of Leqembi that could help accelerate uptake of the #Alzheimers disease therapy.

pharmaphorum.com/news/dose-ho...

Subcutaneous Immunotherapy vs Intravenous Immunotherapy in Cancer: Mechanisms, Clinical Trials, and Future Potential - OncoDaily Subcutaneous immunotherapy in cancer offers safe, effective T cell activation. SCIT boosts vaccine efficacy and may improve access to immunotherapy globally.

Subcutaneous Immunotherapy vs Intravenous Immunotherapy in Cancer: Mechanisms, Clinical Trials, and Future Potential

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO #Subcutaneous #Intravenous #SCIT

Medication Administration
#Post170

#MedicationSafety #6Rights #OralMedication #Sublingual #Buccal #Topical #Transdermal #IVTherapy #Intramuscular #Subcutaneous #NursingProtocols #PatientSafety #PRNmeds #STATorders

#subcutaneous

First sub-cutaneous ocrevus infusion today. Premeds all in.
#ms #multiplesclerosis #chronicillness #chroniclife #ocrevus #subcutaneous #infusion

Original post on lethallava.land

I am very proud to announce that I have written a beginner's guide to giving a subcutaneous HRT injection, to try to help new trans people get started.

uwu.network/~sink/blog/2025/04/trans...

I sincerely hope that this can be useful to someone, and please let me know what […]

Weekly at home infusions
Have questions you would like to ask?
I'll try to answer!

#cvid #pI #scig #immunodeficiency #immunocompromised #homeinfusion #primareyimmunodrficiency #Subcutaneous #cutaquig #subcutaneousinfusion
#askme

#Phaeoacremonium tuscanicum and Phaeoacremonium indicum sp. nov. associated with #subcutaneous #phaeohyphomycosis
doi.org/10.1080/2150...
@tandfresearch.bsky.social

A marker pen loaded with pufferfish toxin could help treat chronic pain - Advanced Science News Scientists have developed a marker pen to deliver tetrodotoxin, a powerful neurotoxin found in pufferfish, to treat severe skin pain.

“It may seem counterintuitive, but scientists are investigating a potent #neurotoxin found in #pufferfish known as #tetrodotoxin to relieve lingering, hard-to-treat pain in the skin known as chronic #subcutaneous pain.”: buff.ly/5TzS5mw

#ChronicPain #PainRelief

#Subcutaneous nivolumab approved by
@fda.gov across all indications - follows approval of SC atezolizumab in Sept 2024.

Will this be the preferred route of administration or will this suppress the development of new biosimilars?

@oncodaily.bsky.social @hemoncwarner.bsky.social

On December 27, 2024, @fda.gov approved ✅ #Subcutaneous nivolumab 💉across approved adult, solid tumor indications, ❌ except in combination with intravenous ipilimumab

www.fda.gov/drugs/resour...

✨✨✨✨✨✨✨✨✨✨✨✨✨
@oncoalert.bsky.social

Tomorrow join us if you're in the #BAUS22 at Birmingham.
Satellite symposium on #subcutaneous #extranatomical #ureteral #bypass for complex ureteral strictures.
@BAUSurology

Frontiers | Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections Since the 1970s, outpatient parenteral antimicrobial therapy (OPAT) has been a viable option for patients who require intravenous antibiotics when hospitaliz...

Our concept paper about #Outpatient #Subcutaneous Antimicrobial Therapy (#OSCAT): a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections such as #BJI or #PJI! Freely downloadable here ➡️

frontiersin.org/article/10.338…